NCT07851077Not yet recruiting
Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV
Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV (STRIVE)
Source: ClinicalTrials.gov · Last updated 1 Oct 2026
Brief summary (registry, in English)
HIV stigma, poverty, and racism contribute to high rates of mental health problems and impede treatment for young sexually minoritized men living with and vulnerable to HIV. Intersectional interventions can reduce barriers and promote access to health services, thus preventing poor health outcomes including HIV transmission related behaviors. The STRIVE intervention will address public and internalized HIV stigma and thus reduce the duration of untreated HIV and mental health problems among young men living with or vulnerable to HIV.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 3900 (estimated)
- First submitted
- 26 Aug 2026
- Start date
- 1 Jan 2028
- Primary completion date
- 1 Jul 2028
- Lead sponsor
- City University of New York, School of Public Health
- Diseases
- HIV
- NCT number
- NCT07851077
What you commit to
- Study type: Interventional
- Planned participants: 3900
- From 1 Jan 2028 to the primary completion date, 1 Jul 2028
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- N/A
Who the study is looking for
- YSMM from the New York area aged 18-30 who are either living with HIV or vulnerable to HIV.
Age in the registry: 18 years to 30 years · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.